Home > Insider Trading > Filing (0001209191-19-060531)

Filing Details

Accession Number:: 0001209191-19-060531
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-13 20:04:50
Reporting Period:: 2019-12-13

Accepted Time:: 2019-12-13 20:04:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510487	Principia Biopharma Inc.	PRNB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1506218	C. Roy Hardiman	C/O Principia Biopharma Inc. 220 E. Grand Avenue South San Francisco CA 94080	Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-12-13	871	$4.72	121,014	No	4	M	Direct
Common Stock	Acquisiton	2019-12-13	4,129	$5.00	125,143	No	4	M	Direct
Common Stock	Disposition	2019-12-13	3,381	$49.20	121,762	No	4	S	Direct
Common Stock	Disposition	2019-12-13	1,619	$49.83	120,143	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-12-13	871	$0.00	871	$4.72
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-12-13	4,129	$0.00	4,129	$5.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,758		2025-02-25	No	4	M	Direct
0		2025-07-20	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,376	Indirect	See footnote

Footnotes

Includes 2,500 shares and 441 shares acquired under the Employment Stock Purchase Plan on May 15, 2019 and November 15, 2019 respectively.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Represents the weighted average sales price per share. The shares sold at prices ranging from $48.49 to $49.48 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents the weighted average sales price per share. The shares sold at prices ranging from $49.57 to $50.04 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Shares indirectly held by Roy Hardiman, as Custodian for Riley James Hardiman, Under California Uniform Transfers to Minors Act, of which the Reporting Person is a custodian and may be deemed to share voting and dispositive power over these shares.
The stock option vested and became exercisable as to 25% of the shares subject to the option on January 5, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
The stock option vested and became exercisable as to 25% of the shares subject to the option on July 21, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.